Latest News on Mylan
Showing of 0 - 10 from 9 results
Mylan - Total results - 9
Jul 29, 2019
What Pfizer-Mylan potential merger means for Indian pharma; can ICICI Bank stock continue to fly; read all this and more on Moneycontrol ProMoneycontrol Pro offers curated markets data, independent equity analysis, insights into investment styles and exclusive trading recommendations
Jul 29, 2019
Pfizer in talks to merge off-patent drugs business with Mylan in a stock deal; plans to form global generic drug giant: ReportPfizer Inc plans to combine its off-patent business, which includes Lipitor cholesterol pills and male impotence drug Viagra, with Mylan NV
Oct 04, 2017
Natco Pharma zooms 20% as partner's injection gets USFDA nodUS Food and Drug Administration granted approval to the Natco Pharma's marketing partner Mylan's injection used for treatment of relapsing forms of multiple sclerosis
Feb 17, 2017
Biocon and Mylan get USFDA approval to jointly develop biologic productThe proposed biosimilar Pegfilgrastim is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace
Jun 11, 2015
India scraps import duties on AIDS drugs to battle shortage in Naco effortsGovernment officials have previously said about a lack of participation by local drugmakers in the tenders floated by the Naco to procure drugs.
Jan 18, 2014
Biocon to start selling breast cancer drug next monthCANMAb will be available at about 25 percent discount to the current list price of the reference product - Roche's Herceptin - in India, which is already significantly lower than its price in developed markets, it added.
Sep 27, 2013
It's a done deal: Mylan gets US nod to buy Strides' unit AgilaThe companies will have to divest assets needed to make 11 generic injectable drugs as a condition of approving the deal, the FTC said.
Sep 03, 2013
Cabinet clears Mylan's Rs 5,168 cr deal to acquire AgilaMylan had set the fourth quarter of 2013 as the expected time for the transaction to be completed subject to regulatory approvals.
Feb 28, 2013
US drug maker Mylan buys Strides Arcolab unit for $1.6 bnGeneric drugmaker Mylan said it will buy a unit of Strides Arcolab for $1.6 billion to expand its presence in the fast-growing injectable drugs market.